RESEARCH TRIANGLE PARK, N.C. (May 3, 2016) – Soybeans, once considered such a simple crop to grow and market, is becoming more complicated. It’s downright confusing when you consider that some new soybean traits are pending import/export approvals in other countries. In fact, until certain soybean traits receive full international approval, many grain elevators will not accept those soybeans.
The American Soybean Association confirmed that fact with its recent announcement that elevators will accept some traited soybeans. Growers can find more information on the ASA website.
Fortunately, there is a soybean trait available that growers can count on this year. LibertyLink® soybeans have all of the necessary domestic and international approvals and will be accepted by elevators this fall.
“LibertyLink soybeans come with the best genetics, yielding up to 2.1 bu/A more than Roundup Ready 2 Yield® soybeans,” said Malin Westfall, soybean marketing manager for Bayer. “You also get excellent weed control when you complete the system by applying Liberty® herbicide.“
Westfall added that the LibertyLink system is a simply better solution with very low risk, in part because all grain elevators may accept LibertyLink soybeans. It’s also a non-volatile, neighbor-friendly herbicide.
“Growers planning to use a traited soybean know they have a weed issue. That’s why they choose traits,” said Malin Westfall, soybean marketing manager for Bayer. “We’re here to help growers control those weeds, get the best yields, and ensure they can market in the fall what they plant in the spring.“
Andy Sekel, a grower in Allen County, Indiana agrees. “Last year and this year, we planted all LibertyLink soybeans and that’s what we seem to like. We think their varieties are stronger. We had good success with weed control, but the yields were just unbelievable. On a 73 acre piece we yielded 90.5 bu/A and our overall farm average was 69.5 bu/A,” shared Sekel. “I would say I’m very satisfied planting LibertyLink soybeans. I think I can make anywhere from $10 to $75/A more, depending on the circumstances. And I think [LibertyLink soybeans] are possibly a stronger bean and healthier bean plant. So I think we’re going to continue to stick with this.”
Bayer is committed to bringing new technology and solutions for agriculture and non-agricultural uses. For questions concerning the availability and use of products, contact a local Bayer representative, or visit Crop Science, a division of Bayer, online at www.CropScience.Bayer.us.
Visit the Bayer Connect - Social Hub for social media, recent news, blog posts, videos and more from Crop Science, a division of Bayer.
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com
Bayer Media Hotline, 1-862-404-5118, or
Crop Science, a Division of Bayer
Tel: (919) 549-5395
Tel: (630) 955-2603
Find more information at CropScience.Bayer.us.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.